PubRank

S Hoshida

Author PubWeight™ 21.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993 2.20
2 Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 1999 1.32
3 Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 1994 1.07
4 Whole-body hyperthermia provides biphasic cardioprotection against ischemia/reperfusion injury in the rat. Circulation 1998 0.95
5 A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart. J Mol Cell Cardiol 1998 0.94
6 Time course of tolerance to ischemia-reperfusion injury and induction of heat shock protein 72 by heat stress in the rat heart. J Mol Cell Cardiol 1997 0.92
7 Heat shock-induced manganese superoxide dismutase enhances the tolerance of cardiac myocytes to hypoxia-reoxygenation injury. J Mol Cell Cardiol 1997 0.92
8 Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol 2000 0.90
9 Detection of oxygen-derived free radical generation in the canine postischemic heart during late phase of reperfusion. Circ Res 1990 0.88
10 Role of free radicals and neutrophils in canine myocardial reperfusion injury: myocardial salvage by a novel free radical scavenger, 2-octadecylascorbic acid. Cardiovasc Res 1989 0.88
11 Free radical generation coupled with arachidonate lipoxygenase reaction relates to reoxygenation induced myocardial cell injury. Cardiovasc Res 1993 0.87
12 The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol 2000 0.85
13 Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res 1990 0.85
14 Neutrophil-induced myocardial cell damage and active oxygen metabolites. Jpn Circ J 1991 0.85
15 Involvement of cytokines in the mechanism of whole-body hyperthermia-induced cardioprotection. Circulation 2000 0.82
16 Alpha 1-adrenergic stimulation induces cardiac tolerance to hypoxia via induction and activation of Mn-SOD. Am J Physiol 1996 0.81
17 Double orifice mitral valve associated with non-compaction of left ventricle. Heart 2001 0.79
18 Calcium overload and cardiac myocyte cell damage induced by arachidonate lipoxygenation. Am J Physiol 1994 0.78
19 Monophosphoryl lipid A provides biphasic cardioprotection against ischaemia-reperfusion injury in rat hearts. Br J Pharmacol 1999 0.78
20 Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes. Am J Physiol 1998 0.77
21 Polymorphonuclear leukocyte activity and ventricular arrhythmia in acute myocardial infarction. Am J Cardiol 1988 0.77
22 Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction. Int J Cardiol 1985 0.77
23 Polymorphonuclear leukocytes-induced injury in hypoxic cardiac myocytes. Free Radic Biol Med 1994 0.76
24 [Continuous infusion of isosorbide dinitrate in intractable rest angina pectoris: report of a case]. J Cardiol Suppl 1989 0.75
25 [Prostanoids and coronary circulation]. Nihon Rinsho 1982 0.75
26 Augmented platelet reactivity and thromboxane A2 production possible aggravating factors in unstable angina. Jpn Circ J 1986 0.75
27 Increased production of arachidonate metabolites in an occlusion-reperfusion model of canine myocardial infarction. Cardiovasc Res 1987 0.75
28 [Evaluation of left ventricular function and assessment of the various factors affecting it in patients with acute myocardial infarction (author's transl)]. Nihon Naika Gakkai Zasshi 1981 0.75
29 The effect of CV-4151, a selective inhibitor of thromboxane synthetase, on prostanoid formation and platelet aggregation in humans. Cardiovasc Drugs Ther 1988 0.75
30 Intravascular ultrasonic evidence by constant cross-sectional area of atherosclerotic plaques during coronary vasomotion in humans. Eur Heart J 1997 0.75
31 Histochemical and immunocytochemical observations of endocrine cells and amine-containing cells in the gastric mucosa of rats with experimental ulceration. Cell Mol Biol Incl Cyto Enzymol 1978 0.75
32 Clinical evaluation of left ventricular function in acute myocardial infarction--analysis of factors affecting left ventricular function. Jpn Circ J 1982 0.75
33 Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism. Jpn Circ J 1986 0.75
34 Altered lipoxygenase metabolites and leukocyte involvement in an acute occlusion-reperfusion model of canine myocardial infarction. Jpn Circ J 1987 0.75
35 Determination of plasma thromboxane B2 by radioimmunoassay: methodological problems and accuracy. Adv Prostaglandin Thromboxane Leukot Res 1985 0.75
36 [A case with Fabry disease]. J Cardiol Suppl 1989 0.75
37 Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy. Eur J Nucl Med 2001 0.75
38 Arachidonate metabolism in myocardial ischemia and reperfusion. J Mol Cell Cardiol 1988 0.75
39 [Clinical characteristics of congestive heart failure following acute myocardial infarction in patients with previous myocardial infarction]. Nihon Naika Gakkai Zasshi 1983 0.75
40 [Acquisition of myocardial ischemic tolerance and its clinical significance]. Jpn Circ J 1992 0.75